English  |  正體中文  |  简体中文  |  2808638  
???header.visitor??? :  26768978    ???header.onlineuser??? :  325
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"von hoff daniel d"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國立成功大學 2016-05-14 Nanoliposomal irinotecan in metastatic pancreatic cancer Reply Chen, Li-Tzong; Wang-Gillam, Andrea; Von Hoff, Daniel D.; Bayever, Eliel; Belanger, Bruce
國立成功大學 2016-02-06 Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyoergy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayle;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean F.;Hubner, Richard A.;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi;Moyo, Victor;Belanger, Bruce;Dhindsa, Navreet;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong
國立成功大學 2016-02-01 Updated overall survival analysis of NAPOLI-1: Phase III study of nanoliposomal irinotecan (nal-IRI, MM-398), with or without 5-fluorouracil and leucovorin (5-FU/LV), versus 5-FU/LV in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy. Wang-Gillam, Andrea;Li, Chung-Pin;Bodoky, Gyorgy;Dean, Andrew;Shan, Yang-Shen;Jameson, Gayle S.;Macarulla, Teresa;Lee, Kyung-Hun;Cunningham, David;Blanc, Jean-Frederic;Hubner, Richard;Chiu, Chang-Fang;Schwartsmann, Gilberto;Siveke, Jens T.;Braiteh, Fadi S.;Moyo, Victor M.;Belanger, Bruce;Bayever, Eliel;Von Hoff, Daniel D.;Chen, Li-Tzong
國立成功大學 2016 Expanded analyses of NAPOLI-1: Phase 3 study of nal-IRI (MM-398), with or without 5-fluorouracil (5FU) and leucovorin (LV), versus 5-fluorouracil and leucovorin (5FU/LV), in metastatic pancreatic cancer (mPAC) previously treated with gemcitabine-based therapy Siveke, Jens T.;Chen, Li-Tzong;Von Hoff, Daniel D;Li, Chung-Pin;Wang-Gillam, Andrew;Bodoky, Gyorgy;Dean, Andrew;Shan, Yan-Shen;Jameson, Gayel S;Macarulla, T.;Lee, K-H;Cunningham, D.;Blanc, J-F;Hubner, R. A.;Chiu, C-F;Schwartsmann, G.;Braiteh, F.;Moyo, V.;Belanger, B.;Bayever, E.

Showing items 1-4 of 4  (1 Page(s) Totally)
1 
View [10|25|50] records per page